Matthew C. Kapusta - 02 Jul 2026 Form 4 Insider Report for uniQure N.V. (QURE)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
07 Jul 2026, 16:47:25 UTC
Prior SEC filing
26 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Christian Klemt, Attorney-in-Fact

Key filing fact

Matthew C. Kapusta filed Form 4 for uniQure N.V. (QURE) on 07 Jul 2026.

Key facts

  • This page summarizes Matthew C. Kapusta's Form 4 filing for uniQure N.V. (QURE).
  • 5 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 07 Jul 2026, 16:47.

Change

  • Previous filing in this sequence was filed on 26 Jun 2026.
  • Current net transaction value: -$952,051.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001536290 Primary reporting owner

Kapusta Matthew C

Relationship
CEO, Managing Director, Director
Address
C/O UNIQURE N.V., PAASHEUVELWEG 25A, AMSTERDAM, NETHERLANDS
Signature
/s/ Christian Klemt, Attorney-in-Fact
Signature date
07 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

QURE transaction

Ordinary Shares

Options Exercise

Transaction value
Shares
+21,082
Change %
+4.1%
Price
$19.39*
Shares after
540,309
Date
02 Jul 2026
Ownership
Direct
Footnotes
F1
QURE transaction

Ordinary Shares

Sale

Transaction value
$408,756
Shares
-9,200
Change %
-1.7%
Price
$44.43
Shares after
531,109
Date
02 Jul 2026
Ownership
Direct
Footnotes
F1, F2
QURE transaction

Ordinary Shares

Sale

Transaction value
$194,531
Shares
-4,282
Change %
-0.81%
Price
$45.43
Shares after
526,827
Date
02 Jul 2026
Ownership
Direct
Footnotes
F1, F3
QURE transaction

Ordinary Shares

Sale

Transaction value
$348,764
Shares
-7,600
Change %
-1.4%
Price
$45.89
Shares after
519,227
Date
02 Jul 2026
Ownership
Direct
Footnotes
F1, F4

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

QURE transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares
-21,082
Change %
-100%
Price
$0.000000*
Shares after
0
Date
02 Jul 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
21,082
Exercise price
$19.39
Footnotes
F1, F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 5 footnotes

Footnote F1

The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on October 5, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.

Footnote F2

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $44.10 to $44.80. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F3

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.00 to $45.95. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F4

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.48 to $46.10. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F5

The Stock Option vested in full on January 26, 2022.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .